@article{826eaa9abfdc4ac1a1f194ed6be12d30,
title = "Treatment advances in blastic plasmacytoid dendritic cell neoplasm",
author = "Naveen Pemmaraju",
note = "Funding Information: Dr Pemmaraju has done consulting for or received honoraria from Celgene, Stemline, e-squared, Incyte, Novartis, Mustang Bio, Roche Diagnostics, and LFB; received research funding or clinical trials support from Stemline, Novartis, AbbVie, Samus, Cellectis, Plexxikon, Daiichi Sankyo, Affymetrix, and Patient Power, and received grants/funding from Affymetrix and the SagerStrong Foundation.",
year = "2019",
month = apr,
language = "English (US)",
volume = "17",
pages = "207--209",
journal = "Clinical Advances in Hematology and Oncology",
issn = "1543-0790",
publisher = "Millennium Medical Publishing, Inc.",
number = "4",
}